Iboxx $ High Yield Cor (HYG.US)

Close: 76.81 (+0.09), May 13, 2022
Negative

Low risk

Automatic technical analysis. Short term, May 13, 2022

Iboxx $ High Yield Corporate Bd Ishares has broken the falling trend channel down in the short term, which indicates an even stronger falling rate. There is no support in the price chart and further decline is indicated. In case of a positive reaction, the stock has resistance at 80.00 dollar. RSI below 30 shows that the momentum of the stock is strongly negative in the short term. Investor have steadily reduced the price to sell the stock, which indicates increasing pessimism and continued falling prices. However, particularly in big stocks, low RSI may be a sign that the stock is oversold and that there is a chance for a reaction upwards. The stock is overall assessed as technically negative for the short term.

Recommendation one to six weeks: Negative (Score: -82)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-0.28%3 770.17+0.12%
5 days63.950.85%3 496.88-1.01%
22 days4.621.98%3 031.85-4.35%
66 days-0.103.42%3 397.26-8.14%

More analyses of Iboxx $ High Yield Corporate Bd Ishares

chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Candlesticks 22 Days
Candlesticks
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Short term
Short term: Negative
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Medium term
Medium term: Negative
chart Iboxx $ High Yield Corporate Bd Ishares (HYG) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+